Prominent players in medical aesthetics market are Allergan, plc (Ireland), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera, Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Nestlé S.A. (Switzerland), Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox, Inc. (South Korea), Sientra, Inc. (US), Sinclair Pharma plc (UK), Syneron Medical, Ltd. (US), and Valeant Pharmaceuticals International, Inc. (US).
Medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6% from 2018 to 2023. Medical aesthetics market in Asia Pacific, on other hand, is projected to witness highest growth rate during forecast period.
Report also tracks & analyzes competitive developments in market like product launches, enhancements, and approvals; acquisitions; partnerships and collaborations; & expansions.
Rise in demand of medical aesthetics market report due to minimally invasive reconstruction surgeries, increase in road accidents and trauma cases, high prevalence of congenital face and tooth deformities, technological advancements, growth in awareness programs, such as breast reconstructive awareness campaign (launched in the U.S.), high incidence of breast cancer, and rise in number of cosmetology surgeons drive the medical aesthetic devices market growth.
Report studies medical aesthetics market based on product, end user, & region. Report also studies factors (like drivers, restraints, opportunities, & challenges) which affect market growth.
It analyzes opportunities & challenges in market for stakeholders & provides details of competitive landscape for key players.
1 Medical aesthetics product manufacturers, suppliers, and providers
2 Academic institutions and private research institutions
3 Hospitals and clinics
4 Beauty centres and spas
5 Research organizations
6 Market research companies and consultants
Medical aesthetics market in Asia Pacific, on other hand, is projected to witness the highest growth rate during the forecast period. Factors such as rising consumer knowledge and interest in procedures, strong local economies, aggressive marketing by leading US and European companies in Asia, rising medical tourism, and an increase in awareness about aesthetics are supporting the growth of the medical aesthetics market in the Asia Pacific.
The medical aesthetics market report profiles key players who are involved in the manufacturing and commercialization of medical aesthetic products/devices and analyzes their core competencies. Convenient replacement of dysfunctional/missing body parts caused due to accidents, trauma, and other congenital disorders is also possible by use of aesthetic implants.
Break-up of primary participants is mentioned below:
- By Company Type: Tier 1 - 33%, Tier 2 - 46%, and Tier 3 - 21%
- By Designation: C-level - 26%, Director-level - 20%, and Others - 54%
- By Region: North America - 33%, Europe - 29%, Asia Pacific - 24%, and the RoW - 14%
The demand for dental implants has increased as they appear natural and realistic as compared to other tooth replacement procedures, do not hamper the aesthetic beauty of an individual, and are convenient to use and highly durable. In addition, these implants offer improved denture retention, reduce chances of bone resorption, and aid in preservation of natural tooth structure.
Report at www.reportsnreports.com/.aspx?name=401761 .
The facial aesthetics products segment is expected to account for the largest market share in 2018, while the thread lift products segment is expected to register the highest growth rate during the forecast period. The high growth of this segment is primarily attributed to the growing focus on aesthetics and increasing consumer willingness to pay for aesthetic treatments.
Reasons to Access the Report:
The medical aesthetics market in the Asia Pacific, on the other hand, is projected to witness the highest growth rate during the forecast period. Factors such as rising consumer knowledge and interest in procedures, strong local economies, aggressive marketing by leading US and European companies in Asia, rising medical tourism.